MPJE: MULTISTATE PHARMACY JURISPRUDENCE EXAMINATION • PHARMACY AND PHARMACIST PRACTICE

Compounding Competency — Apply competency training requirements for personnel engaged in compounding

Ensuring patient safety through legally mandated training, assessment, and documentation for all compounding personnel.

Historical Context & Motivation

Pharmacy compounding has ancient roots, but the formal regulation of compounding personnel competency is a relatively modern development driven by patient safety crises. For centuries, pharmacists prepared individualized medications with little standardized oversight regarding the training of those who performed compounding tasks. The assumption was that a pharmacist's professional education provided sufficient preparation, but this assumption was tested as compounding grew in scale and complexity, particularly with the rise of sterile compounding in hospital and outpatient settings.

Several high-profile contamination events throughout the late twentieth and early twenty-first centuries revealed devastating gaps in compounding quality assurance, many of which were directly traceable to inadequately trained personnel. These tragedies catalyzed sweeping regulatory reforms at both the federal and state levels, establishing the competency training frameworks that pharmacy students must understand for the MPJE and for professional practice.

1997
FDA Modernization Act (FDAMA)
Congress codified the distinction between pharmacy compounding and drug manufacturing in Section 503A, implicitly establishing that compounding required specific professional competencies beyond standard drug dispensing.
2004
USP <797> Published
The United States Pharmacopeia issued the first enforceable standards for sterile compounding, including mandatory personnel training and competency assessment through media fill testing and gloved fingertip sampling.
2012
NECC Meningitis Outbreak
Contaminated methylprednisolone injections from the New England Compounding Center caused 76 deaths and over 750 infections, exposing catastrophic failures in personnel competency and oversight.
2013
Drug Quality and Security Act (DQSA)
Congress enacted the DQSA, creating Section 503B for outsourcing facilities under FDA oversight and reinforcing state board authority over 503A pharmacies, both with heightened personnel training mandates.
2023
Revised USP <797> and New USP <795>
Major revisions to USP chapters modernized competency assessment requirements, expanded training documentation standards, and introduced formal requirements for nonsterile compounding personnel competency under USP <795>.

The central question that these regulatory milestones address is straightforward yet profoundly important: How do we ensure that every individual who touches a compounded preparation possesses the knowledge, skills, and verified competency to protect patients from harm? The answer lies in a systematic framework of initial training, ongoing assessment, and rigorous documentation that the MPJE expects you to apply across various practice scenarios.

Core Principles & Definitions

Compounding competency training is built upon a regulatory architecture that spans federal law, USP standards, and state board regulations. Understanding the foundational principles requires clarity on who must be trained, what they must demonstrate, and how compliance is documented and enforced. The following core concepts form the backbone of every competency training program in pharmacy compounding.

1

Designated Person (DP)

Under USP standards, the Designated Person is the pharmacist or qualified individual responsible for overseeing all compounding operations, including designing and implementing the competency training program for all compounding personnel.
2

Compounding Personnel

This term encompasses all individuals involved in any aspect of compounding — pharmacists, pharmacy technicians, students, and anyone who enters controlled compounding areas. Each must demonstrate competency appropriate to their assigned tasks.
3

Initial vs. Ongoing Competency

Training is not a one-time event. Personnel must complete initial competency assessment before compounding independently, followed by periodic reassessment at defined intervals (e.g., every 6 or 12 months depending on the compounding category).
4

Aseptic Technique Qualification

For sterile compounding under USP <797>, personnel must pass media fill testing and gloved fingertip and thumb sampling to demonstrate that they can compound without introducing microbial contamination.
5

Documentation Requirements

All training activities, competency assessments, and corrective actions must be documented and maintained as part of the pharmacy's quality assurance records. State boards of pharmacy and accrediting bodies may inspect these records during routine or for-cause inspections.
KEY TAKEAWAY
Think of compounding competency training like a pilot's certification program. A pilot doesn't just learn to fly once — they undergo initial training, pass practical check rides (analogous to media fill tests), and must regularly recertify. Similarly, compounding personnel must demonstrate and re-demonstrate their skills at defined intervals, and every assessment is logged in a permanent record. Just as an airline cannot let an uncertified pilot fly passengers, a pharmacy cannot permit untrained or unassessed personnel to compound medications for patients.

Visual Explanation — Competency Training Framework

The competency training process follows a cyclical framework that begins with didactic education and progresses through practical demonstration, formal assessment, and documented re-evaluation. The diagram below illustrates how each stage feeds into the next, creating a continuous quality improvement loop that protects both patients and pharmacy operations.

The competency training cycle shows six interconnected stages overseen by the Designated Person. Note the feedback loop: personnel who fail any competency assessment must undergo retraining before being authorized to compound, and all personnel must be periodically reassessed even after initial authorization.

As the diagram demonstrates, compounding competency is not a linear process but rather a continuous cycle. The Designated Person bears ultimate responsibility for ensuring that each phase is executed rigorously and that documentation accompanies every step. State boards of pharmacy frequently cite failure to maintain current competency records as a basis for disciplinary action, making this cycle both a patient safety imperative and a legal compliance requirement.

Mechanism — USP Standards and Federal/State Requirements

The regulatory framework governing compounding competency operates at three interlocking levels: federal statute (primarily the DQSA), national standards (USP chapters), and state pharmacy practice acts. Understanding how these layers interact is essential for MPJE preparation because exam questions frequently test your ability to identify which standard applies and what it requires in specific scenarios.

USP <797>: Sterile Compounding Personnel Requirements

Under USP <797>, all personnel who prepare compounded sterile preparations (CSPs) must complete training that covers: proper hand hygiene procedures, garbing and gowning techniques, aseptic manipulation skills, achieving and maintaining ISO Class 5 conditions in the primary engineering control (PEC), proper use of the PEC (e.g., laminar airflow workbench, compounding aseptic isolator), cleaning and disinfection of compounding areas, and the principles behind beyond-use dating. Competency assessment for sterile compounding specifically requires successful completion of media fill testing (also called process simulation), in which the compounder prepares a sterile product using microbiological growth medium instead of actual drug. If bacterial growth is detected after incubation, the personnel member has failed and cannot compound sterile preparations until retraining is complete and a passing media fill is achieved.

USP <795>: Nonsterile Compounding Personnel Requirements

The revised USP <795> formalized training requirements for nonsterile compounding personnel, an area that was historically less regulated. Personnel must demonstrate competency in: interpreting and following master formulation records and compounding records, performing accurate calculations (including unit conversions and concentration adjustments), selecting appropriate equipment and ingredients, applying proper compounding techniques for the dosage form (e.g., trituration, geometric dilution, levigation), and implementing quality control measures such as weight variation checks and pH testing. While media fill testing is not required for nonsterile compounding, the Designated Person must verify competency through direct observation, written assessments, and review of compounding records.

USP <800>: Hazardous Drug Compounding

Personnel who compound hazardous drugs (HDs) must meet all applicable requirements under USP <795> or <797> plus additional training mandated by USP <800>. This includes competency in the use of closed-system transfer devices (CSTDs), proper handling and disposal of HD waste, spill containment procedures, appropriate use of personal protective equipment (PPE) such as chemotherapy gloves and gowns, and decontamination and deactivation protocols. Training must be documented initially and repeated at least every 12 months.

State Board Variation — MPJE Alert
While USP standards establish the national floor for competency requirements, individual state boards of pharmacy may impose additional or more stringent requirements. For example, some states require specific continuing education hours in compounding, mandate additional competency evaluations beyond USP minimums, or require pharmacist-in-charge sign-off on all competency records. On the MPJE, always apply the most stringent applicable standard — if state law exceeds USP requirements, the state law controls.

Detailed Breakdown — Competency Assessment Methods

Different compounding categories require different assessment methods, and each method serves a distinct purpose in verifying personnel readiness. The following table and diagram summarize the principal competency assessment tools recognized under USP standards, their application domains, and their reassessment frequencies.

Summary of principal competency assessment methods across USP chapters
Assessment MethodApplicable USP ChapterWhat It EvaluatesReassessment Frequency
Media Fill TestUSP <797>Aseptic technique during sterile compounding; detects microbial contamination introduced by the compounderInitially, then every 6 months (Category 1) or 6 months (Category 2)
Gloved Fingertip & Thumb Sampling (GFTS)USP <797>Effectiveness of hand hygiene and garbing; detects microbial contamination on gloved handsInitially (×3 consecutive passes), then every 6 months
Direct ObservationUSP <795>, <797>, <800>Real-time assessment of technique, adherence to SOPs, and proper use of equipment and PPEInitially, then every 12 months
Written AssessmentUSP <795>, <797>, <800>Knowledge of compounding principles, calculations, safety procedures, and regulatory requirementsInitially, then every 12 months
Spill Management DrillUSP <800>Ability to safely contain, clean, and dispose of hazardous drug spills; proper donning of protective equipmentInitially, then every 12 months
Comparison of competency assessment requirements across the three major compounding categories. Note that hazardous drug compounding requires all assessments from the applicable base chapter (USP <795> or <797>) plus additional HD-specific competencies under USP <800>.

A critical point for MPJE preparation is understanding the initial GFTS requirement: personnel must pass three consecutive, separate gloved fingertip and thumb sampling tests before being authorized to compound sterile preparations independently. This is more rigorous than most other initial assessments and reflects the higher risk profile of sterile compounding. A single failed GFTS attempt means the entire sequence must restart after remediation.

Worked Example — Implementing a Competency Training Program

Consider the following scenario: A community pharmacy has just installed a laminar airflow workbench and plans to begin offering Category 1 sterile compounding services. The pharmacist-in-charge (who is also the Designated Person) must establish a competency training program for a new pharmacy technician, Alex, who has never compounded sterile preparations before.

Setting Up Alex's Competency Training Program
1
Step 1 — Identify Applicable StandardsBecause the pharmacy will perform Category 1 sterile compounding, the Designated Person must ensure Alex's training complies with USP <797> requirements. The DP also consults the state board of pharmacy regulations to identify any additional state-specific requirements (e.g., mandatory continuing education hours, additional documentation elements). Since the pharmacy does not compound hazardous drugs, USP <800> does not apply at this time.
Applicable standard: USP <797> + state pharmacy practice act
2
Step 2 — Complete Didactic TrainingBefore Alex touches any compounding equipment, the DP provides comprehensive didactic training covering: SOPs for hand hygiene and garbing, aseptic technique principles, proper use of the laminar airflow workbench (LAFW), cleaning and disinfection procedures, the pharmacy's master formulation records, and beyond-use dating guidelines for Category 1 CSPs. Alex must also review the pharmacy's quality assurance plan. The DP documents the date, duration, topics covered, and Alex's acknowledgment of completion.
Didactic training completed and documented with date and topics
3
Step 3 — Conduct Practical (Hands-On) TrainingThe DP supervises Alex performing each compounding procedure under direct observation. Alex practices proper hand washing technique (≥30 seconds with appropriate antimicrobial soap), correct garbing sequence (shoe covers, hair cover, face mask, hand washing, sterile gown, then sterile gloves), and aseptic manipulations within the LAFW. The DP corrects errors in real time and documents each training session.
Practical skills demonstrated under direct observation
4
Step 4 — Perform Initial Competency AssessmentsAlex must pass three critical assessments: (a) a written examination on compounding knowledge, (b) three consecutive successful gloved fingertip and thumb sampling (GFTS) tests showing 0 colony-forming units (CFU) per hand, and (c) a media fill test in which a sterile growth medium is compounded using aseptic technique and incubated for 14 days — no turbidity (microbial growth) is an acceptable result. If Alex fails any single GFTS attempt, the sequence of three consecutive passes must restart from the beginning after retraining.
All three assessments passed: written exam, 3× GFTS (0 CFU each), media fill (no growth)
5
Step 5 — Document and AuthorizeThe DP creates a competency record for Alex that includes: all training dates and content, assessment dates and results (including incubation start/end dates for media fills), the DP's signature and credentials, and the date Alex is authorized to compound independently. This record is filed in the pharmacy's quality assurance documentation and must be available for state board inspection. The DP also notes in the record that Alex's next reassessment is due within 6 months for GFTS and media fill testing.
Alex authorized to compound Category 1 CSPs; reassessment due in 6 months

Comparing Competency Requirements: Nonsterile vs. Sterile vs. Hazardous Drug

Understanding the differences and overlaps among competency requirements across compounding categories is frequently tested on the MPJE. The following table provides a side-by-side comparison that highlights the escalating rigor as the risk profile of the compounded preparation increases.

Comparative competency requirements across USP compounding chapters
Requirement ElementNonsterile (USP <795>)Sterile (USP <797>)Hazardous Drug (USP <800>)
Didactic TrainingRequiredRequiredRequired (HD-specific)
Practical TrainingRequiredRequiredRequired (HD-specific PPE & CSTDs)
Media Fill TestNot requiredRequiredRequired if sterile HD compounding
GFTSNot requiredRequired (3× initial)Required if sterile HD compounding
Spill Management DrillNot requiredNot requiredRequired
Reassessment IntervalEvery 12 monthsEvery 6 months (media fill & GFTS)Every 12 months (HD-specific)
DocumentationRequiredRequiredRequired
KEY TAKEAWAY
Think of the competency requirements as a tiered security system. Nonsterile compounding is like a standard home security system — it provides baseline protection with alarms and locks (written assessments, direct observation). Sterile compounding is like a hospital-grade clean room access system — it adds biometric verification (media fill, GFTS) because the consequences of a breach are far more severe. Hazardous drug compounding adds a HAZMAT layer on top of whichever base system applies, requiring additional specialized training for the unique dangers involved. The MPJE expects you to identify which tier applies and what specific assessments that tier demands.

Connection to Advanced Regulatory Concepts

Compounding competency training does not exist in isolation — it connects to broader regulatory frameworks that the MPJE tests across multiple content domains. Understanding these connections allows you to answer questions that integrate competency requirements with other aspects of pharmacy law and practice.

How competency training connects to other MPJE content domains
Related ConceptConnection to Competency Training
Quality Assurance (QA) ProgramsCompetency records are a required component of the pharmacy's overall QA program. Failed assessments trigger corrective and preventive actions (CAPAs) within the QA framework.
Section 503A vs. 503B Facilities503A pharmacies follow state board oversight and USP standards. 503B outsourcing facilities are registered with the FDA and must follow current good manufacturing practices (cGMPs), which impose even more rigorous personnel qualification requirements.
Pharmacy Technician Scope of PracticeState laws define whether and to what extent pharmacy technicians may perform compounding tasks. Competency training does not expand a technician's legal scope of practice — they must be both legally authorized and demonstrably competent.
Board of Pharmacy InspectionsState board inspectors routinely review competency training records during pharmacy inspections. Deficiencies in documentation are among the most commonly cited violations, potentially resulting in fines, required corrective action plans, or license suspension.
Pharmacist Liability and NegligenceIf a patient is harmed by a compounded preparation and the pharmacy cannot produce competency records for the personnel who compounded it, this creates strong evidence of negligence in civil litigation and may support disciplinary action by the state board.

As pharmacy practice continues to evolve, emerging areas such as office-use compounding (preparations compounded for a prescriber's office without patient-specific prescriptions), veterinary compounding, and compounding for clinical trials are generating new discussions about how competency requirements should be adapted. State boards are increasingly aligning their rules with USP standards while adding jurisdiction-specific requirements. For MPJE success, remain alert to the principle that federal standards set the minimum baseline, but state law always prevails when it is more stringent.

Practice Problems

PROBLEM 1CONCEPTUAL
A pharmacy prepares nonsterile compounded preparations under USP <795>. A new pharmacy technician completes didactic training and a written examination but has not yet been directly observed compounding by the Designated Person. Can this technician independently compound nonsterile preparations? Explain your reasoning.
PROBLEM 2BASIC CALCULATION
A pharmacy has 8 employees who perform sterile compounding. Under USP <797>, gloved fingertip and thumb sampling (GFTS) and media fill testing must be repeated every 6 months. How many total GFTS and media fill assessments must the Designated Person schedule over a 24-month period for all sterile compounding personnel (assuming no personnel changes and no failures requiring re-testing)?
PROBLEM 3INTERMEDIATE
A pharmacy technician at a hospital pharmacy successfully passes her first and second gloved fingertip and thumb sampling (GFTS) tests with 0 CFU per hand. On her third GFTS attempt, the results show 2 CFU on the right hand. What must happen next under USP <797> before this technician can compound sterile preparations independently?
PROBLEM 4APPLIED
A state board of pharmacy inspector visits a compounding pharmacy and discovers the following: (1) The pharmacy compounds both nonsterile and Category 1 sterile preparations. (2) One pharmacy technician's most recent media fill test was performed 9 months ago. (3) The same technician's competency training file contains no documentation of initial GFTS testing. (4) The Designated Person states that GFTS was performed but the results were not recorded. Identify all violations and explain what corrective actions the pharmacy must take.
PROBLEM 5CRITICAL THINKING
A pharmacy currently compounds only nonsterile preparations under USP <795>. The pharmacy owner wants to begin compounding sterile hazardous drug preparations (e.g., compounded chemotherapy agents). Construct a comprehensive outline of the competency training program that the Designated Person must develop before any personnel can begin compounding these preparations. Address all applicable USP chapters and explain why each element is necessary.

Lesson Summary

Compounding competency training is a legally mandated, cyclical process that applies to all personnel involved in any aspect of pharmacy compounding. The Designated Person oversees the entire program, which consists of didactic training, practical (hands-on) training, and formal competency assessments that vary by compounding category. Nonsterile compounding (USP <795>) requires written assessments and direct observation with annual reassessment. Sterile compounding (USP <797>) adds media fill testing and gloved fingertip and thumb sampling (GFTS) — including three consecutive initial passes — with reassessment every six months. Hazardous drug compounding (USP <800>) layers additional requirements for PPE competency, spill management drills, and CSTD use on top of the applicable base chapter.

Every training activity and assessment result must be documented and maintained for state board inspection, and personnel who fail any assessment must undergo retraining and successful reassessment before resuming compounding. For the MPJE, remember that USP standards establish the national minimum, but state law prevails when it is more stringent. Competency training is not merely a regulatory checkbox — it is the primary mechanism through which pharmacies ensure that every compounded preparation meets the quality standards necessary to protect patient safety.

Varsity Tutors • MPJE: Multistate Pharmacy Jurisprudence Examination • Compounding Competency — Apply competency training requirements for personnel engaged in compounding